[1] |
Claudon M, Cosgrove D, Albrecht T, et al. EFSUMB Study Group. Guidelines and good clinical practice recommendations for Contrast Enhanced Ultrasound (CEUS) [J]. Ultraschall Med, 2008, 29: 28-44.
|
[2] |
Dietrich CF, Maddalena ME, Cui XW, et al. Liver tumor characterization-review of the literature [J]. Ultraschall Med, 2012, 33 Suppl 1: S3-S10.
|
[3] |
Nicolau C, Catala V, Vilana R, et al. Evaluation of hepatocellular carcinoma using SonoVue, a second generation ultrasound contrast agent: correlationwith cellular differentiation [J]. Eur Radiol, 2004, 14(6): 1092-1099.
|
[4] |
Wu W, Chen MH, Sun M, et al. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis [J]. Chin Med J (Engl), 2012, 125(17): 3104-3109.
|
[5] |
Facciorusso A, Licinio R, Muscatiello N, et al.Transarterial chemoembolization: evidences from the literature and applications in hepatocellular carcinoma patients [J]. World J Hepatol, 2015, 7(16): 2009-2019.
|
[6] |
Wáng YX, De Baere T, Idée JM, et al.Transcatheter embolization therapy in liver cancer: an update of clinical evidences [J]. Chin J Cancer Res, 2015, 27(2): 96-121.
|
[7] |
Pacella CM, Bizzarri G, Cecconi P, et al. Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization [J]. Radiology, 2001, 219(3): 669-678.
|
[8] |
Wu W, Chen M, Yan K, et al. Evaluation of contrast-enhanced ultrasound for diagnosis of dysplastic nodules with a focus of hepatocellular carcinoma in liver cirrhosis patients [J]. Chin J Cancer Res, 2015, 27(1): 83-89.
|
[9] |
Fan ZH, Chen MH, Dai Y, et al. Evaluation of primary malignancies of the liver using contrast-enhanced sonography: correlation with pathology [J]. AJR Am J Roentgenol, 2006, 186(6): 1512-1519.
|
[10] |
Beaton C, Cochlin D, Kumar N. Contrast enhanced ultrasound should be the initial radiological investigation to characterise focal liver lesions [J]. Eur J Surg Oncol, 2010, 36(1): 43-46.
|
[11] |
高军喜, 姚兰辉. 超声造影对肝脏肿瘤诊断价值的Meta分析 [J]. 中国医学影像技术, 2009, 25(4): 646-649.
|
[12] |
El-Assal ON, Yamanoi A, Soda Y, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver [J]. Hepatology, 1998, 27(6): 1554-1562.
|
[13] |
李功杰, 杨立, 史晓林, 等. 原发性肝癌肿瘤微血管形态特征与其生物学特性的关系 [J]. 世界华人消化杂志, 2005, 13(13): 1503-1506.
|
[14] |
Jang HJ, Kim TK, Burns PN, et al. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation [J]. Radiology, 2007, 244(3): 898-906.
|
[15] |
李功杰, 杨立, 史晓林, 等. 原发性肝癌血供分型与其病理分化程度关系的研究 [J]. 军事医学科学院院刊, 2004, 28(4): 398-399.
|
[16] |
Endo T, Kozaka K, Kobayashi S, et al. Hemodynamics and progression of a hypervascular focus in a borderline lesion of hepatocellular carcinoma: analysis by angiography-assisted CT and histopathology [J]. Jpn J Radiol, 2014, 32(2): 69-79.
|
[17] |
Quaia E, Calliada F, Bertolotto M, et al. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride–filled microbubble contrast agent: diagnostic performance and confidence [J]. Radiology, 2004, 232(2): 420-430.
|
[18] |
Nicolau C, Vilana R, Catala V, et al. Importance of evaluating all vascular phases on contrast-enhanced sonography in the differentiation of benign from malignant focal liver lesions [J]. AJR Am J Roentgenol, 2006, 186(1): 158-167.
|